ALX Oncology Is Maintained at Buy by UBS

Dow JonesAug 16 10:38 ET

Express News | ALX Oncology Holdings Inc : UBS Cuts Target Price to $4 From $25

ReutersAug 16 10:00 ET

Express News | Millennium Management LLC Reports 5.6% Passive Stake in ALX Oncology Holdings as of August 6 - SEC Filing

ReutersAug 13 16:19 ET

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsAug 13 06:31 ET · Ratings

Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept

TipRanksAug 13 06:19 ET · Ratings

ALX Oncology | 10-Q: Q2 2024 Earnings Report

SEC announcementAug 12 16:08 ET · Announcements